0 Commentarios
0 Acciones
1453 Views
0 Vista previa
Buscar
Descubre nuevas personas, crear nuevas conexiones y hacer nuevos amigos
- Please log in to like, share and comment!
- Antisense Oligonucleotides Market Key Players Profile Outlook and Forecast Till 2032The Reports and Insights, a leading market research company, has recently releases report titled “Antisense Oligonucleotides Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Antisense Oligonucleotides Market share, size, trends, and growth forecasts. The report...0 Commentarios 0 Acciones 470 Views 0 Vista previa
- Antisense Oligonucleotides Market Size is Witnessing to Grow at a CAGR of 9.5% from 2023 to 2032The global Antisense Oligonucleotides market size exceeded US$ 1.7 billion in 2021 and is anticipated to expand at a CAGR of 9.5% from 2023 to 2032. The exhaustive Global Antisense Oligonucleotides market report focuses on the important aspects of the market imbibing recent global trends are. The market research report refers to production capacity, consumption, import, and export for all major...0 Commentarios 0 Acciones 1918 Views 0 Vista previa
- Emerging Antisense Oligonucleotides Market driven by Increasing R&D Investment in Therapeutics DevelopmentAntisense oligonucleotides work by binding to messenger RNA (mRNA), which stops the production of proteins present in the mRNA. They have gained popularity in treating rare genetic diseases such as spinal muscular atrophy, cardiovascular diseases, and cancer. The market growth is driven by rising investment in research and development for therapeutics discovery and development of novel...0 Commentarios 0 Acciones 1194 Views 0 Vista previa
- The Antisense Oligonucleotides Market is Estimated to Witness High Growth Owing to Opportunity in Rare Diseases TreatmentAntisense oligonucleotides are synthesized short DNA or RNA strands that bind to messenger RNA (mRNA) and prevent protein synthesis by either degrading the target mRNA or blocking its translation. These oligonucleotides are used to treat rare diseases caused by single-gene mutations such as Duchenne muscular dystrophy and spinal muscular atrophy. The global antisense oligonucleotides market is...0 Commentarios 0 Acciones 1206 Views 0 Vista previa